Pathfinders in Biopharma

By: RBC Capital Markets
  • Summary

  • Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
    Copyright 2024 RBC Capital Markets
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Former Investor Who Chose Broadcasting Over Biotech ETFs
    Sep 30 2024

    Former biotech investor, Brad Loncar has pivoted his career from investing to reporting on the industry. Instead of serving the biotech bubble, he hopes to reach a wide audience with interest in science. Loncar explains why he switched careers and sets out his ambitions for his channel, Biotech TV.

    Show more Show less
    12 mins
  • Can AI Solve Molecule Mysteries that will Unlock Simpler Drug Discovery?
    Aug 29 2024

    The hardest parts of drug discovery will be vastly simplified if the mysteries of molecules and proteins can be cracked. That may be beyond human capabilities – but AI is working hard on it. In this episode of RBC’s Pathfinders in Biopharma, Noël Brown is joined by Clarissa Desjardins, CEO of Congruence, and Laksh Aithani, CEO and Co-founder of Charm Therapeutics, to discuss how far the tech can take us.

    Show more Show less
    34 mins
  • Shots-on-Goal Licensing Company Aims for Breakthroughs
    Jul 19 2024

    A very special breed of animals is helping biotech and pharma companies in the quest for new human therapeutics. CFO Kurt Gustafson joins Pathfinders in Biopharma to explain the technologies behind OmniAb’s business model.

    Show more Show less
    14 mins

What listeners say about Pathfinders in Biopharma

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.